Royalty Pharma PLC

CUSIP: 78081BAS2 Class: Corporate Bond - Foreign US$

Holders for Q4 2025 Position Changes for Q4 2025

Note: Option positions (PUT/CALL) are excluded.

Increased Positions (1)

Pacer Advisors, Inc.
Value ($000) $68 (+16.0%) Shares 69,000 (+16.9%)